Aerie Pharmaceuticals Inc

GEODE CAPITAL MANAGEMENT, LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

862,809

Value ($000)

13,054

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	13,054	0.0%	862,809	9/30/2022
2022 Q2	8/12/2022	6,265	0.0%	835,386	6/30/2022
2022 Q1	5/13/2022	6,949	0.0%	763,732	3/31/2022
2021 Q4	2/11/2022	5,884	0.0%	838,313	12/31/2021
2021 Q3	11/12/2021	7,451	0.0%	653,610	9/30/2021
2021 Q2	8/13/2021	12,106	0.0%	756,214	6/30/2021
2021 Q1	5/12/2021	12,460	0.0%	697,287	3/31/2021
2020 Q4	2/12/2021	8,503	0.0%	629,391	12/31/2020
2020 Q3	11/13/2020	7,169	0.0%	609,109	9/30/2020
2020 Q2	8/13/2020	9,029	0.0%	611,772	6/30/2020
2020 Q1	5/14/2020	8,598	0.0%	636,914	3/31/2020
2019 Q4	2/13/2020	14,312	0.0%	592,163	12/31/2019
2014 Q1	5/14/2014	1,048	0.0%	49,469	3/31/2014
2013 Q4	2/14/2014	672	0.0%	37,463	12/31/2013